US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients (March 5)
Shares of the company were up 5.2% in extended trading. The spray, sold under the brand name neffy, will be dosed at 1 ...
KHQA on MSN1d
Blessing Health introduces new FDA-approved nasal spray treatment for resistant depression
Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...
Healio7d
FDA approves epinephrine nasal spray for children aged as young as 4 years
The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in ...
WebMD7d
FDA OKs Nasal Spray for Severe Allergic Reactions in Kids
The FDA has approved Neffy, a needle-free nasal spray, for children aged 4 and up, providing fast and effective treatment for severe allergic reactions and anaphylaxis.
WGNO-TV New Orleans on MSN8d
Nasal spray recalled nationwide; risk of infection: FDA
(WHTM) — The U.S. Food & Drug Administration (FDA) has announced the voluntary recall of a sinus nasal wash bottle system following a confirmed test result of microbial contamination. According to the ...
Managed Healthcare Executive7d
FDA Approves Neffy 1 mg Nasal Spray for Pediatric Patients
Neffy 1 mg is now approved by the FDA to treat pediatric patients who weigh 33 to 65 lbs. Neffy was first FDA-approved as a 2 ...
PharmExec7d
FDA Approves ARS Pharmaceuticals’ neffy for Type 1 Allergic Reactions in Pediatric Patients
The approval of neffy marks the first major advancement in epinephrine delivery for patients over four years of age in more ...
San Diego biotech gets FDA approval for EpiPen alternative for kids
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...
Recall issued for popular nasal medicine sold at Walgreens, H-E-B and Amazon
The FDA recently announced a voluntary recall of a popular Sinu Cleanse nasal spray sold at retailers like H-E-B, Walgreens, ...
GlobalData on MSN7d
FDA approves ARS’ neffy 1mg for paediatric anaphylaxis
The approval is supported by data from clinical trials, including pharmacodynamic and pharmacokinetic responses in adults and ...
ALS News Today6d
Tiziana seeking FDA OK to launch clinical trial of foralumab in ALS
Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...
US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients
The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...